tci Part B Insider - 2004 Issue 18

PHYSICIAN NOTES: Don't Close Off All Off-Label Uses For Oral Chemo Drugs, ASCO Urges

The Centers for Medicare & Medicaid Services proposes to limit coverage for oral chemotherapy drugs to uses listed by the Food & Drug Administration in a drug coverage demonstration project mandated by the Medicare Modernization Act.   But the American Society for Clinical Oncology warns in a recent letter to CMS that the demonstration project will exclude from coverage "at least one significant oral drug that is regarded as an extremely important component of treatment for a deadly blood cancer that strikes many Medicare beneficiaries." ASCO points out that CMS is required to consider off-label uses of cancer...

To read the full article, sign in and subscribe to tci Part B Insider.


Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4800 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles

This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.